Subcutaneous Injections Often considered for achieving more targeted and systemic effects, subcutaneous injections deliver GHK-Cu directly into the body, allowing for higher bioavailability and more predictable concentrations
Human-equivalent dosing extrapolated from animal studies suggests 200 to 500 micrograms per day, administered subcutaneously for musculoskeletal or systemic targets and orally for gut-specific applications
Where trials discuss the resolution of side effects, one trial reported that around half of affected participants taking dutasteride reported spontaneous resolution of symptoms while continuing treatment
Over consistent use, these cumulative effects can result in visibly firmer, smoother, and more youthful-looking skin
GHK-CU accelerates these baseline repair processes, essentially putting your skin into enhanced healing mode